Abstract
Several mutations of the protooncogene RET cause multiple endocrine neoplasia type 2A and type 2B, familial medullary thyroid carcinoma, and Hirschsprung disease and are associated with some sporadic papillary and medullary thyroid carcinomas. This review covers the molecular pathology of RET in relation to those diseases. In addition, the molecular biology of RET is discussed. Finally, recent studies affecting the care of patients with multiple endocrine neoplasia type 2A and 2B are reviewed together with the role of genetic testing in these conditions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
